Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer

Fig. 4

Kaplan-Meier curves of recurrence-free survival of patients with initially resectable CRLM with and without adjuvant chemotherapy stratified by different risk groups. A Total patients. B low-risk group (diploid DNA ploidy and TBS ≤ 3). C moderate-risk group (diploid DNA ploidy and TBS > 3 or nondiploid DNA ploidy and TBS ≤ 3). D high-risk group (nondiploid DNA ploidy and TBS > 3)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us